Post of the day
American

DelMar Pharmaceuticals, Inc. (DMPI: OTCQX U.S.) | DelMar Pha...

VANCOUVER, British Columbia and MENLO PARK, Calif., April 19, 2015 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) (DelMar and the Company), a biopharmaceutical company focused on developing and commercializing proven cancer therapies in new orphan drug indications, today announced positive preclinical data on its lead product candidate VAL-083 (dianhydrogalactitol) for treatment of platinum drug-resistant non-small…